Cargando…
Neurometabolite Levels in Alcohol Use Disorder Patients During Baclofen Treatment and Prediction of Relapse to Heavy Drinking
Background and Aims: Baclofen, a GABA(B) agonist, is used as a treatment for alcohol dependence. We aimed to examine brain metabolites following administration of baclofen or placebo in alcohol dependent individuals enrolled in a randomized placebo-controlled trial. Methods: Participants included 31...
Autores principales: | Morley, Kirsten C., Lagopoulos, Jim, Logge, Warren, Chitty, Kate, Baillie, Andrew, Haber, Paul S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131632/ https://www.ncbi.nlm.nih.gov/pubmed/30233431 http://dx.doi.org/10.3389/fpsyt.2018.00412 |
Ejemplares similares
-
Baclofen Response in Alcohol Dependent Patients Concurrently Receiving Antidepressants: Secondary Analysis From the BacALD Study
por: Heng, Sovandara, et al.
Publicado: (2018) -
Impaired Decision-Making and Skin Conductance Responses Are Associated with Reward and Punishment Sensitivity in Individuals with Severe Alcohol Use Disorder
por: Logge, Warren B., et al.
Publicado: (2023) -
Editorial: Baclofen in the Treatment of Alcohol Use Disorder
por: de Beaurepaire, Renaud, et al.
Publicado: (2019) -
The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective
por: de Beaurepaire, Renaud, et al.
Publicado: (2019) -
R(+)-Baclofen, but Not S(−)-Baclofen, Alters Alcohol Self-Administration in Alcohol-Preferring Rats
por: Lorrai, Irene, et al.
Publicado: (2016)